Literature DB >> 12548364

High-frequency electrical stimulation of the subthalamic nucleus in Parkinson's disease: kinetic and kinematic gait analysis.

M Rizzone1, M Ferrarin, A Pedotti, B Bergamasco, E Bosticco, M Lanotte, P Perozzo, A Tavella, E Torre, M Recalcati, A Melcarne, L Lopiano.   

Abstract

In the advanced phase of Parkinson's disease (PD), gait disturbances represent one of the main causes of disability. Several studies demonstrated that high-frequency electrical stimulation (HFS) of the subthalamic nucleus (STN) significantly improves the motor symptoms of PD. This study was finalised to quantitatively analyze the effect of STN HFS on gait of PD patients, through a three-dimensional gait analysis system. Ten PD patients were studied, with and without STN HFS. The results demonstrated that STN HFS significantly improves all the main gait parameters in PD patients.

Entities:  

Mesh:

Year:  2002        PMID: 12548364     DOI: 10.1007/s100720200090

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  4 in total

Review 1.  Deep brain stimulation.

Authors:  Joel S Perlmutter; Jonathan W Mink
Journal:  Annu Rev Neurosci       Date:  2006       Impact factor: 12.449

2.  Analysis of the time course of the effect of subthalamic nucleus stimulation upon hand function in Parkinson's patients.

Authors:  Ben Waldau; Daniel A Clayton; Lynne B Gasperson; Dennis A Turner
Journal:  Stereotact Funct Neurosurg       Date:  2011-01-19       Impact factor: 1.875

3.  A computational modelling approach to investigate different targets in deep brain stimulation for Parkinson's disease.

Authors:  Marco Pirini; Laura Rocchi; Mariachiara Sensi; Lorenzo Chiari
Journal:  J Comput Neurosci       Date:  2008-06-14       Impact factor: 1.621

4.  Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson disease.

Authors:  Samer D Tabbal; Mwiza Ushe; Jonathan W Mink; Fredy J Revilla; Angie R Wernle; Minna Hong; Morvarid Karimi; Joel S Perlmutter
Journal:  Exp Neurol       Date:  2008-02-14       Impact factor: 5.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.